Actualités

12 February 2019

While The NHS Drags Its Heels On PrEP, This Is How Men Are Being Affected

Although NHS England increased places in the PrEP Impact Trial to 13,000 participants in summer and recently said it hopes to extend this to 26,000 before 2020, it is yet to confirm when these places will become available – or what will happen when the three-year trial is up. Around 40% of trial clinics across England are currently turning away gay and bisexual men due to oversubscription, according to the Terrence Higgins Trust. Six men who’ve failed to access PrEP have told HuffPost UK the experience has left them feeling “depressed”, “anxious” and “frustrated”.
12 February 2019

A Trailblazing HIV Doctor Who Helped Thousands Access PrEP Has Died At Age 44

Dr Mags Portman, a hero of the LGBT and HIV community, leaves behind a husband, two children, and a legacy: getting PrEP into the hands of those who need it.
12 February 2019

Correlation between HIV, rectal gonorrhea could help PrEP trial designs

Rectal gonorrhea incidence may serve to estimate what HIV incidence would have been had trial participants not received PrEP, according to study findings.
11 February 2019

To Halt HIV, Advocates Push For PrEP Outreach To Black Women

In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women's health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women. Not much happened.
7 February 2019

Trump's HIV pledge comes as Gilead pumps cash into Truvada for PrEP

Gilead is looking to eventually sub out Truvada for its newer HIV drug Descovy when it comes to pre-exposure prophylaxis. But in the meantime, it’s socking cash into promoting the older brand for PrEP.